NCT06965738

Brief Summary

The goal of this randomized clinical trial is to determine the pain intensity during rest and swallowing in patients undergoing transoral robotic surgery for tonsil lesions with and without buccal fat reconstruction. The main question it aims to answer is: does buccal fat after transoral robotic surgery reduce pain after surgery? Additional questions to be explored include if there is a difference in swallowing, complication rates, pain medication usage, and feeding tube usage. Participants will be asked to rate their pain and swallowing on a visual analogue scale after surgery. The group will be compared compared to a control group that undergoes transoral robotic surgery without buccal fat reconstruction.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_2

Timeline
12mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Jun 2025May 2027

First Submitted

Initial submission to the registry

March 31, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 11, 2025

Completed
21 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

1.8 years

First QC Date

March 31, 2025

Last Update Submit

May 19, 2025

Conditions

Keywords

Transoral Robotic SurgeryBuccal FatPostoperative Pain

Outcome Measures

Primary Outcomes (1)

  • Postoperative pain during rest and swallowing

    Postoperative pain during rest and swallowing on visual analogue scale at multiple time points

    Once each at the following timepoints: 1-2 week preoperatively, postoperative day 1-3, postoperative day 7-10, postoperative day 21-28

Secondary Outcomes (7)

  • Surgical Complications

    30 days postoperatively

  • Opioid usage

    30 days postoperatively

  • Postoperative Hemorrhage

    30 days postoperatively

  • Speech and Swallowing

    Once each at the following timepoints: 1-2 week preoperatively, postoperative day 7-10, postoperative day 21-28

  • Oral Diet

    Once each at the following timepoints: 1-2 week preoperatively, postoperative day 7-10, postoperative day 21-28

  • +2 more secondary outcomes

Study Arms (2)

Transoral lateral oropharyngectomy alone

ACTIVE COMPARATOR

Transoral lateral oropharyngectomy without buccal fat reconstruction

Procedure: No buccal fat reconstruction

Transoral lateral oropharyngectomy with buccal fat reconstruction

EXPERIMENTAL

Transoral lateral oropharyngectomy with buccal fat reconstruction

Procedure: Buccal fat reconstruction

Interventions

Ipsilateral buccal fat rotation flap for reconstruction of lateral oropharyngectomy defect

Transoral lateral oropharyngectomy with buccal fat reconstruction

No reconstruction of lateral oropharyngectomy defect

Transoral lateral oropharyngectomy alone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18
  • Require a transoral robotic lateral oropharyngectomy as a result of the following conditions :
  • Early - intermediate stage tonsillar squamous cell carcinoma (T1-2N0-1 p16+/- SCC of the palatine tonsils)
  • Early -intermediate stage salivary gland tumors of the palatine tonsils
  • based on FNA, Core biopsy, Punch biopsy
  • Ability to understand and willing to sign a written informed consent

You may not qualify if:

  • History of prior head and neck squamous cell carcinoma, or prior head and neck radiotherapy
  • Presence of retropharyngeal lymphadenopathy
  • Presence of bilateral lymphadenopathy, or patients requiring bilateral neck dissections.
  • Patients with trismus at baseline
  • Patients with psychological risk factors for persistent opioid use or drug addiction
  • Need for open surgery (transcervical lateral oropharyngectomy), free tissue transfer, or alternative regional flap.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Toronto General Hospital

Toronto, Ontario, M5G 2C4, Canada

Location

Related Publications (1)

  • Xie M, de Almeida J, Goldstein D, Martino R, Liu YF, Allen B, Xu W, Hueniken K, Yao CM. Buccal fat applied to transoral robotic lateral oropharyngectomy defects to lessen radical tonsillectomy pain (BOLT): a single-centre, phase II, parallel, randomised control trial study protocol. BMJ Open. 2025 Dec 12;15(12):e106125. doi: 10.1136/bmjopen-2025-106125.

MeSH Terms

Conditions

Tonsillar NeoplasmsOropharyngeal NeoplasmsPain, Postoperative

Condition Hierarchy (Ancestors)

Pharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsPharyngeal DiseasesStomatognathic DiseasesOtorhinolaryngologic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Christopher Yao, MD FRCSC

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR
  • John R de Almeida, MD MSc FRCSC

    University Health Network, Toronto

    STUDY DIRECTOR
  • Michael Xie, MD FRCSC

    University Health Network, Toronto

    STUDY CHAIR
  • Rosemary Martino, Ma MSc PhD

    University Health Network, Toronto

    STUDY CHAIR

Central Study Contacts

Christopher Yao, MD FRCSC

CONTACT

Michael Xie, MD FRCSC

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 31, 2025

First Posted

May 11, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

May 21, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

De-identified data, randomization, primary and secondary outcomes

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
May 2027-May 2037
Access Criteria
IPD can be shared on a case by case basis by contacting the principal investigator, data will be de-identified, extent of data will be determined and decided upon by the principal investigator, data will be shared via secure email and data transfer agreement

Locations